Royal Bank of Canada’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 6334 |
|
|
2025
Q1 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 6072 |
|
|
2024
Q4 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 6192 |
|
|
2024
Q3 | $3K | Sell |
1,000
-428
| -30% | -$1.28K | ﹤0.01% | 6108 |
|
|
2024
Q2 | $3K | Buy |
1,428
+428
| +43% | +$899 | ﹤0.01% | 6243 |
|
|
2024
Q1 | $3K | Sell |
1,000
-153
| -13% | -$459 | ﹤0.01% | 6118 |
|
|
2023
Q4 | $5K | Buy |
1,153
+34
| +3% | +$147 | ﹤0.01% | 6100 |
|
|
2023
Q3 | $3K | Sell |
1,119
-185
| -14% | -$496 | ﹤0.01% | 6203 |
|
|
2023
Q2 | $4K | Buy |
1,304
+275
| +27% | +$844 | ﹤0.01% | 6255 |
|
|
2023
Q1 | $4K | Hold |
1,029
| – | – | ﹤0.01% | 6214 |
|
|
2022
Q4 | $4K | Buy |
1,029
+18
| +2% | +$70 | ﹤0.01% | 6297 |
|
|
2022
Q3 | $5K | Buy |
1,011
+11
| +1% | +$54 | ﹤0.01% | 6216 |
|
|
2022
Q2 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 6332 |
|
|
2022
Q1 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 6883 |
|
|
2021
Q4 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 6782 |
|
|
2021
Q3 | $5K | Sell |
1,000
-1,000
| -50% | -$5K | ﹤0.01% | 6594 |
|
|
2021
Q2 | $8K | Sell |
2,000
-2,000
| -50% | -$8K | ﹤0.01% | 6429 |
|
|
2021
Q1 | $19K | Buy |
4,000
+2,000
| +100% | +$9.5K | ﹤0.01% | 5941 |
|
|
2020
Q4 | $6K | Buy |
2,000
+738
| +58% | +$2.21K | ﹤0.01% | 6014 |
|
|
2020
Q3 | $3K | Buy |
1,262
+1
| +0.1% | +$2 | ﹤0.01% | 5722 |
|
|
2020
Q2 | $4K | Buy |
1,261
+1,039
| +468% | +$3.3K | ﹤0.01% | 5607 |
|
|
2020
Q1 | $0 | Buy |
+222
| New | – | ﹤0.01% | 6116 |
|
|
2019
Q4 | – | Sell |
-369
| Closed | -$1K | – | 6167 |
|
|
2019
Q3 | $1K | Buy |
+369
| New | +$1K | ﹤0.01% | 5717 |
|
|
2018
Q2 | – | Sell |
-9
| Closed | – | – | 5894 |
|
|
2018
Q1 | $0 | Hold |
9
| – | – | ﹤0.01% | 5682 |
|
|
2017
Q4 | $0 | Hold |
9
| – | – | ﹤0.01% | 5745 |
|
|
2017
Q3 | $0 | Buy |
+9
| New | – | ﹤0.01% | 5908 |
|